CBD for endometriosis: does it help and how to use it to reduce pain

Endometriosis affects about 10% of women of reproductive age, which in Poland means over one and a half million patients, and the path to diagnosis takes an average of seven to ten years. When hormone therapy does not provide full pain control, and anti-inflammatory medications cease to be sufficient, many women seek alternatives. CBD regularly appears in this context and deserves a fair assessment: neither outright rejection nor promises that the data do not support. Below you will find what is actually known, what is not known, and the practical implications of both.

KEY INFORMATION
• There is no randomized clinical trial evaluating CBD for endometriosis; the strongest data comes from a survey of 484 patients (Armour et al., 2019).
• In this survey, cannabis and CBD oil were among the highest-rated self-help methods, alongside heat and dietary changes.
• CBD does not cure endometriosis. Activation of the CB1 receptor increased the size of lesions in mice (Sanchez et al., 2017).
• CBD inhibits CYP3A4, which metabolizes some progestogens, so combining it with hormone therapy requires the approval of a gynecologist.

Dlaczego endometrioza boli?

Because tissue similar to the endometrial lining grows outside the uterine cavity, on the ovaries, peritoneum, or intestines, and responds to the hormonal cycle just like the endometrium: it thickens, bleeds, and becomes inflamed. The difference is that the blood has no outlet. This leads to chronic inflammation, adhesions, and scarring.

Pain has several independent sources here, which explains why it is so difficult to control with a single medication. The inflammatory component arises from cytokines and prostaglandins released around the lesions. The neuropathic component comes from the ingrowth of nerve fibers into the lesions and central sensitization, which is a lasting decrease in pain threshold in the spinal cord and brain. The nociceptive component is direct irritation of tissues by adhesions.

The review by Maddern et al. (Frontiers in Physiology, 2020) gathers these mechanisms and points out something that has practical significance: the intensity of pain poorly correlates with the extent of anatomical changes. A patient with minimal lesions may suffer more than a patient with extensive disease. Central sensitization explains this discrepancy better than anatomy alone and is also the reason why surgical treatment does not always end pain.

What do studies really say about CBD for endometriosis?

Less than most texts on the internet suggest. No randomized clinical trial evaluating CBD for this indication has been published yet, so any statement starting with "studies show" should be treated with suspicion, including this article.

The strongest available data comes from a cross-sectional online survey by Armour et al. (BMC Complementary and Alternative Medicine, 2019), which received responses from 484 Australian women aged 18-45 with a confirmed diagnosis. Three-quarters of the respondents used some form of self-help, and among the methods rated highest in terms of their own subjective effectiveness were cannabis, heat, CBD oil, and dietary changes.

It is important to understand what such a result is and what it is not. This is a self-assessment by patients, collected once, without a control group and without blinding, in a group recruited through social media, thus with an overrepresentation of individuals actively seeking alternatives. The placebo effect in chronic pain can be significant. At the same time, 484 confirmed diagnoses are not anecdotal, and the signal is clear enough to justify clinical trials, which are still lacking.

How does the endocannabinoid system participate in endometriosis?

It participates, and measurably so, although not in a way that would yield straightforward therapeutic conclusions. Sanchez et al. (2016) measured the concentrations of endocannabinoids and related mediators in the plasma of women with and without endometriosis throughout the menstrual cycle. The differences turned out to be significant, confirming that this system is involved in the disease.

However, mere involvement does not indicate which way this system should be pushed. This distinction is lost in most popular discussions, yet it is the most important aspect of the entire topic. The fact that a biological system is involved in a disease can be used as an argument for both its inhibition and stimulation.

CBD further complicates the picture because it is not a classical agonist of cannabinoid receptors. It acts as a negative allosteric modulator on CB1, interacts with TRPV1, serotonin receptors 5-HT1A, and the FAAH enzyme that breaks down anandamide. In other words, conclusions from studies on THC or synthetic agonists cannot be directly applied to CBD, although this is often done in texts about cannabis.

Can CBD inhibit the growth of endometriosis lesions?

There is no evidence for this, and one study suggests caution in the opposite direction. Sanchez et al. (2017) investigated the role of the CB1 receptor in the formation of lesions using a mouse model. Mice that were given a CB1 agonist developed larger ectopic changes, while animals lacking active CB1 had milder changes.

This finding reverses the narrative repeated in many articles, which states that cannabinoids inhibit the growth of endometriotic tissue. With CB1 activation in the animal model, the opposite occurred. CBD is not a CB1 agonist, so the result does not directly transfer to it, but it is enough to reject the claim that cannabis "acts on the cause of the disease."

An honest conclusion is therefore as follows: CBD can only be considered as a tool for managing pain and accompanying symptoms, never as a therapy modifying the course of endometriosis. Diagnostics, hormone therapy, and surgical treatment remain the foundation, which nothing in this article replaces.

This has practical implications for one decision that some patients consider: discontinuing hormone therapy in favor of CBD. Nothing in the available data justifies this. Hormone therapy acts on the mechanism of the disease, while CBD at best affects the perception of pain, so switching one for the other means giving up treatment in exchange for possible symptomatic relief. If hormone therapy does not provide control or its side effects are unbearable, the discussion about changing should be with the gynecologist, not with a supplement store.

What do the ESHRE guidelines say about cannabinoids?

They do not recommend them. The guidelines of the European Society of Human Reproduction and Embryology regarding endometriosis do not mention cannabinoids among the recommended pain management methods, citing insufficient clinical data. This position reflects the state of knowledge, not an assessment of the substance itself.

However, the lack of recommendation is not the same as a contraindication, and it's important to understand this difference when discussing with your doctor. The guidelines describe what the scientific society can recommend based on evidence of appropriate quality; in the absence of randomized studies, no recommendation can be made, regardless of how promising the premises are. You can find the full text of the guidelines at eshre.eu.

For a conversation in the office, this has a specific consequence. If you tell your gynecologist that you are using CBD, and they respond that there is no evidence for it, both of you are correct, and it is not a dispute. The lack of evidence describes the state of research, not your experience with pain. Therefore, a sensible conversation concerns something else: whether there are contraindications in your case, whether the medications you are taking interact, and how you will know that the supplement has stopped providing any benefit.

It's also worth asking about things that the guidelines recommend but are often overlooked. For central sensitization, pelvic floor physiotherapy, treatment of neuropathic pain, and psychological support can be effective, and none of these methods compete with CBD or exclude it.

How to dose CBD for endometriosis?

There are no established doses for this indication, so any range provided below is derived from studies on chronic pain, not a clinical recommendation. Treat it as a starting point for discussion with your doctor, not as a prescription.

The meal matters more than it seems. The same dose taken with a fat-rich meal produces a concentration curve area four times higher than on an empty stomach (Birnbaum i in., Epilepsia, 2019), so inconsistency in this one aspect can change the effect more than changing the number of drops. We have detailed the scheme in the text about dawkowaniu CBD, and we have gathered data on painful menstruation in the article about CBD for Menstrual Pain.

Another issue is sleep, which usually deteriorates first with chronic pain and drives a vicious cycle: worse sleep lowers the pain threshold, and stronger pain worsens sleep. A series of cases by Shannon et al. (Permanente Journal, 2019) describes improvements in sleep and reductions in anxiety in some of the 72 patients at doses of 25-75 mg per day. This is a case series from a psychiatric clinic, not a controlled study, but breaking this loop can be a real goal in itself.

What medications may interact with CBD?

Primarily those metabolized by cytochromes CYP3A4 and CYP2C19, which CBD inhibits (Iffland i Grotenhermen, Cannabis and Cannabinoid Research, 2017). In the case of endometriosis, this has specific significance, as some first-line medications belong to this group.

There is one practical rule with no exceptions for this disease: the attending physician must know about CBD before you start using it, not after something starts happening. Endometriosis is treated for years, often with several medications at once, so every new substance enters a system that should not be quietly disturbed.

Also pay attention to signals that indicate CBD should be discontinued and you should consult a doctor: unusual bleeding during hormone therapy, a noticeable change in the severity of side effects from a medication you previously tolerated well, and persistent daytime drowsiness. None of these are dangerous in themselves, but each indicates that something in the system has shifted.

Frequently Asked Questions

Does CBD help with endometriosis pain?

There is no randomized study that would resolve this. The strongest available data is a survey of 484 Australian women with confirmed diagnoses, in which cannabis and CBD oil were among the highest-rated self-help methods (Armour i in., 2019). This is a self-assessment by the patients, not a clinical measurement.

How much CBD should I take for endometriosis?

There are no established doses for this indication. The ranges used in practice, derived from studies on chronic pain, fall between 20 and 40 mg per day, with the possibility of increasing during menstruation. Start with 10 mg in the evening and determine the rest with your attending physician.

Does CBD cure endometriosis?

No. CBD does not eliminate lesions or stop their growth. In a mouse model, activation of the CB1 receptor increased the size of ectopic lesions (Sanchez i in., 2017), so the impact of cannabinoids on the disease itself is neither simple nor unequivocally beneficial.

Can CBD be combined with hormone therapy?

Only after consulting with a gynecologist. CBD inhibits CYP3A4, which metabolizes some progestogens used in endometriosis, which may increase their concentration in the blood and intensify side effects (Iffland and Grotenhermen, 2017).

Does CBD reduce pelvic pain?

The mechanisms of pain in endometriosis include TRPV1 receptors, neurogenic inflammation, and central sensitization (Maddern i in., 2020), and CBD interacts with some of these pathways. However, no clinical study has measured the translation into real relief for patients.

You can find the oils available in the store in the category hemp oils.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-07